Jerry Avorn, M.D., is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. An internist, he has worked as a primary care physician and geriatrician and has been studying drug use and its outcomes for over 25 years.
Niteesh Choudhry, M.D., Ph.D., is an Associate Professor of Medicine at Harvard Medical School and a Hospitalist at Brigham and Women's Hospital whose research focuses on the use of medications to treat common chronic conditions.
Michael Fischer, M.D., M.S., is an Associate Professor of Medicine at Harvard Medical School and a primary care internist who studies cost-effective drug use in outpatient practices.
Connie DiCocco, M.Ed., is the Chief Executive Officer of the Alosa Foundation. Most recently, Connie has worked for Screening for Mental Health since 2002, and was appointed the executive director of the organization in 2008. Her prior experiences include a position as the director of HIV/AIDS education for the American Red Cross of Massachusettes Bay.
Eimir Hurley, B.Sc.(Pharm), MBiostat, is the Program Director of the Alosa Foundation. Her areas of interest include drug utilization and the quality use of medicine and medical tests.
Beverly Andrade, M.B.A., is the Operations Manager of the Alosa Foundation. Prior to joining Alosa, Beverly was with the American Cancer Society for seven years. Beverly has extensive experience in non-profit management having worked at both large national and small local organizations that have a focus on health care and services for the underserved.
Allison Earon, M.P.H., is the Program Manager of the Alosa Foundation. She has experience in both laboratory and qualitative research and her areas of interest include global health and health disparities.
Dan Pelberg, is the Program Assistant of the Alosa Foundation. Prior to Alosa, he worked in India on rural development projects involving health and sanitation.